Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume – Should You Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw an uptick in trading volume on Tuesday . 62,391 shares traded hands during trading, an increase of 118% from the previous session’s volume of 28,598 shares.The stock last traded at $8.6550 and had previously closed at $8.54.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Nihon Kohden Stock Performance

The stock has a 50 day moving average of $9.08 and a two-hundred day moving average of $10.09. The firm has a market capitalization of $1.46 billion, a P/E ratio of 14.49 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY) last announced its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The firm had revenue of $453.10 million during the quarter, compared to analysts’ expectations of $414.40 million. Sell-side analysts predict that Nihon Kohden Corporation will post 0.6 EPS for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.